Location: Zurich, Switzerland
CIK: 0001623624 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 14, 2026
Total Value: $287M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WBD | WARNER BROS DISCOVERY INC | 1,663,164 | $45.67M | 15.9% | $23.73 | +19.0% | COM SER A | 934423104 |
| IHS | IHS HOLDING LIMITED | 4,343,787 | $35.75M | 12.4% | $7.93 | 0.0% | ORD SHS | G4701H109 |
| SLSR | SOLARIS RES INC | 4,084,315 | $35.26M | 12.3% | $3.67 | +156.4% | COM NEW | 83419D201 |
| HOLX | HOLOGIC INC | 405,920 | $30.68M | 10.7% | $75.02 | 0.0% | COM | 436440101 |
| NSC | NORFOLK SOUTHN CORP | 96,385 | $27.66M | 9.6% | $289.05 | +3.2% | COM | 655844108 |
| GTLS | CHART INDS INC | 117,407 | $24.27M | 8.4% | $202.89 | +2.1% | COM | 16115Q308 |
| AAUC | ALLIED GOLD CORP | 740,000 | $22.9M | 8.0% | $29.54 | 0.0% | COM NEW | 01921D204 |
| FOLD | AMICUS THERAPEUTICS INC | 1,101,228 | $15.92M | 5.5% | $10.03 | +42.6% | COM | 03152W109 |
| PEN | PENUMBRA INC | 42,785 | $14.05M | 4.9% | $339.56 | 0.0% | COM | 70975L107 |
| RVMD | REVOLUTION MEDICINES INC | 138,290 | $13.45M | 4.7% | $103.02 | 0.0% | COM | 76155X100 |
| PRA | PROASSURANCE CORP | 368,059 | $9.098M | 3.2% | $24.06 | +0.9% | COM | 74267C106 |
| ACLX | ARCELLX INC | 55,251 | $6.344M | 2.2% | $71.30 | 0.0% | COMMON STOCK | 03940C100 |
| OLPX | OLAPLEX HLDGS INC | 1,415,716 | $2.874M | 1.0% | $1.57 | 0.0% | COM | 679369108 |
| ABVX | ABIVAX SA | 16,200 | $1.804M | 0.6% | $121.55 | — | SPONSORED ADS | 00370M103 |
| GPCR | STRUCTURE THERAPEUTICS INC | 35,000 | $1.687M | 0.6% | $48.20 | — | SPONSORED ADS | 86366E106 |